Watch Ticker

Black Diamond Therapeutics, Inc. Common Stock

Go to Black Diamond Therapeutics, Inc. Common Stock Website

$4.87

(%)

Live

Previous Close

$4.87

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$274.0 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacol...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Should You Buy Black Diamond Therapeutics (BDTX) Ahead of Earnings?

Black Diamond Therapeutics (BDTX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Related tickers: BDTX.

Read Full Article

Black Diamond Therapeutics, Inc - Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

CAMBRIDGE, MA, May 09, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today reported financial results for the first quarter ended March 31, 2024, and provided a corporate update.

Related tickers: BDTX.

Read Full Article

Trending Tickers

CTMX

XNAS

$1.89

(%)

MIMO

XASE

$0.11

(%)

PRSO

XNAS

$1.38

(%)

QQQ

XNAS

$0.00

(%)

FDXTF

$0.00

(%)